ESEdward G. Singleton

Edward G. Singleton

*This is an algorithmically generated author record based on publicly available information.

Edward G. Singleton has a total of 76 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • A Comparison of the Fagerström Test for Cigarette Dependence and Cigarette Dependence Scale in a Treatment-Seeking Sample of Pregnant Smokers

    by Ivan Berlin, Edward G. Singleton, Stephen J. Heishman

    Introduction: Valid and reliable brief measures of cigarette dependence are essential for research purposes and effective clinical care. Two widely-used brief measures of cigarette dependence are the 6-item Fagerström Test for Cigarette Dependence (FTCD) and 5-item Cigarette Dependence Scale (CDS-5). Their respective metric characteristics among pregnant smokers have not yet been studied.


  • Open Access

    Brief Arabic tobacco craving questionnaire: An investigation into craving and heavy smoking in Saudi Arabian males

    by AbdulazizA Albrithen, Edward G Singleton

    Background and Objectives: Research in the United States has shown that craving tobacco is associated with smoking, yet no investigation has been done into the relationship between craving and the use of tobacco in Saudi Arabian smokers. The aim of this cross-sectional study was to examine the craving of tobacco by Saudi males and its influence on daily smoking. Subjects were recruited under the auspices of the Tobacco Control Program in Jeddah City and Riyadh. Methods: The American English version of the tobacco craving questionnaire (TCQ-12) is a valid measure of four distinct aspects (factors) of tobacco craving. The TCQ-12 was translated into Arabic tobacco craving questionnaire (ATCQ-12) and administered to a sample of 322 male smokers. Predictive validity was determined by examining the relationship between the factors and the number of cigarettes smoked per day (CPD). Results: In a general linear multivariate analysis of variance model, CPD increased significantly as either ATCQ-12 Factor 1 (emotionality) or Factor 3 (compulsiveness) increased. A significant Factor 1 by Factor 3 interaction indicated that Factor 1 was a better predictor of heavy smoking, but only when Factor 3 was low. Factor 3 was a better predictor of heavy smoking, but only when Factor 1 was low. Conclusions: The ATCQ-12 is a rapid measure of craving and valid predictor of CPD and heavy smoking. Craving in anticipation of smoking as relief from a negative mood (emotionality) is an indicator of psychological withdrawal symptoms, while craving in anticipation of the inability to control tobacco use (compulsiveness) is an indicator of physical dependence.


  • Chapter 9 Commentary

    by Edward G. Singleton, Jack E. Henningfield

  • Oral Fluid Nicotine Markers to Assess Smoking Status and Recency of Use

    by Karl B Scheidweiler, Gina F Marrone, Diaa M Shakleya, Edward G Singleton, Stephen J Heishman, Marilyn A Huestis

    Oral fluid collection is noninvasive and easily observed making it an attractive matrix for objectively determining smoking status. Despite large intersubject variability, cotinine oral fluid concentrations correlate with cigarettes smoked per day (CPD). Few studies, however, assessed nicotine markers in oral fluid other than cotinine; other markers might improve smoking status assessment and/or time of last cigarette. Smoking histories and oral fluid specimens were collected from nontreatment-seeking light (1-10 CPD) and heavy smokers (greater than 10 CPD) and from environmentally exposed and nonexposed nonsmokers who provided written informed consent for this Institutional Review Board-approved study. Nicotine, cotinine, hydroxycotinine (OH-cotinine), and norcotinine oral fluid concentrations were quantified by liquid chromatography tandem mass spectrometry. Comparison of 1, 3, and 10 ng/mL oral fluid liquid chromatography tandem mass spectrometry cutoffs demonstrated that 10-ng/mL cutoffs performed optimally for cotinine, OH-cotinine, nicotine, and norcotinine identifying 98%, 97%, 88%, and 15% of self-reported smokers; 1% nonsmokers had greater than 10 ng/mL cotinine. No self-reported nonsmoker had greater than 10 ng/mL OH-cotinine, nicotine, or norcotinine. Norcotinine was only identified in smokers' oral fluid. Oral fluid nicotine, cotinine, and nicotine/cotinine ratios were correlated with time of last smoking (r = -0.53, -0.23, and -0.51; P < 0.05) and CPD (r = 0.35, 0.26, and 0.33; P < 0.01), respectively. OH-cotinine performed slightly better than cotinine for distinguishing smokers from nonsmokers and should be considered as an additional oral fluid smoking indicator. Further research is required to determine if oral fluid norcotinine is a marker for distinguishing light and heavy smokers. Moderate correlations suggest nicotine, cotinine, and nicotine/cotinine ratios may be useful for determining smoking recency in "spot samples" collected during nicotine cessation treatment.


  • Tobacco Craving Questionnaire

    by Stephen J. Heishman, Edward G. Singleton, Eric T. Moolchan

  • Relative performance of common biochemical indicators in detecting cigarette smoking

    by Gina F. Marrone, Diaa M. Shakleya, Karl B. Scheidweiler, Edward G. Singleton, Marilyn A. Huestis, Stephen J. Heishman

    Aims  Many cities have banned indoor smoking in public places. Thus, an updated recommendation for a breath carbon monoxide (CO) cut‐off is needed that optimally determines smoking status. We evaluated and compared the performance of breath CO and semiquantitative cotinine immunoassay test strips (urine and saliva NicAlert®) alone and in combination.Design  Cross‐sectional study.Setting  Urban drug addiction research and treatment facility.Participants  Ninety non‐treatment‐seeking smokers and 82 non‐smokers.Measurements  Participants completed smoking histories and provided breath CO, urine and saliva specimens. Urine and saliva specimens were assayed for cotinine by NicAlert® and liquid chromatography‐tandem mass spectrometry (LCMSMS).Findings  An optimal breath CO cut‐off was established using self‐report and LCMSMS analysis of cotinine, an objective indicator, as reference measures. Performance of smoking indicators and combinations were compared to the reference measures. Breath CO ≥5 parts per million (p.p.m.) optimally discriminated smokers from non‐smokers. Saliva NicAlert® performance was less effective than the other indicators.Conclusions  In surveys of smokers and non‐smokers in areas with strong smoke‐free laws, the breath carbon monoxide cut‐off that discriminates most effectively appears to be ≥5 p.p.m. rather than the ≥10 p.p.m. cut‐off often used. These findings may not generalize to clinical trials, regions with different carbon monoxide pollution levels or areas with less stringent smoke‐free laws.


  • An Examination of Drug Craving Over Time in Abstinent Methamphetamine Users

    by Gantt P. Galloway, Edward G. Singleton, Raymond Buscemi, Matthew J. Baggott, René M. Dickerhoof, John E. Mendelson

    Craving for addictive drugs may predict relapse in abstinent addicts. To assess relationships between craving and use, we examined changes in craving for methamphetamine (MA) in a sample of 865 outpatients in a multisite 16‐week MA‐treatment study. Craving was assessed on a 0–100 scale, and MA use was assessed by self‐report and confirmed by urinalysis. We hypothesized that the magnitude of craving would decline (decay) with increased time of abstinence, and that decay would be greater for more frequent MA users, and greater for intravenous (IV) users and smokers as compared to those who used MA intranasally. Craving declined significantly as the number of weeks of consecutive abstinence increased. Rate of decay was greater for IV users and smokers as compared to both intranasal users and oral users, but not for more frequent users of MA. Rate of decay was independent of age, gender, and race/ethnicity. The trajectory to 0 (no) craving was 1 week shorter for females than males because females had significantly lower pretreatment craving scores compared to males. This study confirms that the sooner MA‐dependent people are able to quit using and the longer that they are able to stay abstinent, the more likely it is that their craving for MA will decrease over time. (Am J Addict 2010;00:1–5)